 | • レポートコード：GIR-105X03088 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、カルシウム拮抗薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。カルシウム拮抗薬の種類別市場規模（ジヒドロピリジン、ジルチアゼム、ベラパミル、その他）、用途別市場規模（高血圧、冠状動脈疾患、不整脈、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・カルシウム拮抗薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Aventis、Searle、Bayer、AstraZeneca、Knoll Pharmaceuticals、Wyeth-Ayerst、Novartis、Sanofi、Baiyunshan Pharmaceutical、South China Pharmaceutical Group、Tianjin Tanabe Seiyaku ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ジヒドロピリジン、ジルチアゼム、ベラパミル、その他 ・用途別分析2016年-2026年：高血圧、冠状動脈疾患、不整脈、その他 ・カルシウム拮抗薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・カルシウム拮抗薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・カルシウム拮抗薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・カルシウム拮抗薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・カルシウム拮抗薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Calcium Antagonists market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Calcium Antagonists size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Calcium Antagonists market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Calcium Antagonists market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Dihydropyridine
Diltiazem
Verapamil
Others
Market segment by Application can be divided into
Hypertension
Coronary Artery Disease
Arrhythmia
Ohers
The key market players for global Calcium Antagonists market are listed below:
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
Novartis
Sanofi
Baiyunshan Pharmaceutical
South China Pharmaceutical Group
Tianjin Tanabe Seiyaku
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Calcium Antagonists Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Calcium Antagonists Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Dihydropyridine
1.2.3 Diltiazem
1.2.4 Verapamil
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Calcium Antagonists Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hypertension
1.3.3 Coronary Artery Disease
1.3.4 Arrhythmia
1.3.5 Ohers
1.4 Global Calcium Antagonists Market Size & Forecast
1.4.1 Global Calcium Antagonists Sales in Value (2016-2026))
1.4.2 Global Calcium Antagonists Sales in Volume (2016-2026)
1.4.3 Global Calcium Antagonists Price by Type (2016-2026) & (USD/Unit)
1.5 Global Calcium Antagonists Production Capacity Analysis
1.5.1 Global Calcium Antagonists Total Production Capacity (2016-2026)
1.5.2 Global Calcium Antagonists Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Calcium Antagonists Market Drivers
1.6.2 Calcium Antagonists Market Restraints
1.6.3 Calcium Antagonists Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Calcium Antagonists Product and Services
2.1.4 Pfizer Calcium Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Aventis
2.2.1 Aventis Details
2.2.2 Aventis Major Business
2.2.3 Aventis Calcium Antagonists Product and Services
2.2.4 Aventis Calcium Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Searle
2.3.1 Searle Details
2.3.2 Searle Major Business
2.3.3 Searle Calcium Antagonists Product and Services
2.3.4 Searle Calcium Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer Calcium Antagonists Product and Services
2.4.4 Bayer Calcium Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Calcium Antagonists Product and Services
2.5.4 AstraZeneca Calcium Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Knoll Pharmaceuticals
2.6.1 Knoll Pharmaceuticals Details
2.6.2 Knoll Pharmaceuticals Major Business
2.6.3 Knoll Pharmaceuticals Calcium Antagonists Product and Services
2.6.4 Knoll Pharmaceuticals Calcium Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Wyeth-Ayerst
2.7.1 Wyeth-Ayerst Details
2.7.2 Wyeth-Ayerst Major Business
2.7.3 Wyeth-Ayerst Calcium Antagonists Product and Services
2.7.4 Wyeth-Ayerst Calcium Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Calcium Antagonists Product and Services
2.8.4 Novartis Calcium Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Calcium Antagonists Product and Services
2.9.4 Sanofi Calcium Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Baiyunshan Pharmaceutical
2.10.1 Baiyunshan Pharmaceutical Details
2.10.2 Baiyunshan Pharmaceutical Major Business
2.10.3 Baiyunshan Pharmaceutical Calcium Antagonists Product and Services
2.10.4 Baiyunshan Pharmaceutical Calcium Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 South China Pharmaceutical Group
2.11.1 South China Pharmaceutical Group Details
2.11.2 South China Pharmaceutical Group Major Business
2.11.3 South China Pharmaceutical Group Calcium Antagonists Product and Services
2.11.4 South China Pharmaceutical Group Calcium Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Tianjin Tanabe Seiyaku
2.12.1 Tianjin Tanabe Seiyaku Details
2.12.2 Tianjin Tanabe Seiyaku Major Business
2.12.3 Tianjin Tanabe Seiyaku Calcium Antagonists Product and Services
2.12.4 Tianjin Tanabe Seiyaku Calcium Antagonists Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Calcium Antagonists Sales by Manufacturer
3.1 Global Calcium Antagonists Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Calcium Antagonists Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Calcium Antagonists
3.4 Market Concentration Rate
3.4.1 Top 3 Calcium Antagonists Manufacturer Market Share
3.4.2 Top 6 Calcium Antagonists Manufacturer Market Share
3.5 Global Calcium Antagonists Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Calcium Antagonists Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Calcium Antagonists Market Size by Region
4.1.1 Global Calcium Antagonists Sales in Volume by Region (2016-2026)
4.1.2 Global Calcium Antagonists Revenue by Region (2016-2026)
4.2 North America Calcium Antagonists Revenue (2016-2026)
4.3 Europe Calcium Antagonists Revenue (2016-2026)
4.4 Asia-Pacific Calcium Antagonists Revenue (2016-2026)
4.5 South America Calcium Antagonists Revenue (2016-2026)
4.6 Middle East and Africa Calcium Antagonists Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Calcium Antagonists Sales in Volume by Type (2016-2026)
5.2 Global Calcium Antagonists Revenue by Type (2016-2026)
5.3 Global Calcium Antagonists Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Calcium Antagonists Sales in Volume by Application (2016-2026)
6.2 Global Calcium Antagonists Revenue by Application (2016-2026)
6.3 Global Calcium Antagonists Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Calcium Antagonists Sales by Type (2016-2026)
7.2 North America Calcium Antagonists Sales by Application (2016-2026)
7.3 North America Calcium Antagonists Market Size by Country
7.3.1 North America Calcium Antagonists Sales in Volume by Country (2016-2026)
7.3.2 North America Calcium Antagonists Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Calcium Antagonists Sales by Type (2016-2026)
8.2 Europe Calcium Antagonists Sales by Application (2016-2026)
8.3 Europe Calcium Antagonists Market Size by Country
8.3.1 Europe Calcium Antagonists Sales in Volume by Country (2016-2026)
8.3.2 Europe Calcium Antagonists Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Calcium Antagonists Sales by Type (2016-2026)
9.2 Asia-Pacific Calcium Antagonists Sales by Application (2016-2026)
9.3 Asia-Pacific Calcium Antagonists Market Size by Region
9.3.1 Asia-Pacific Calcium Antagonists Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Calcium Antagonists Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Calcium Antagonists Sales by Type (2016-2026)
10.2 South America Calcium Antagonists Sales by Application (2016-2026)
10.3 South America Calcium Antagonists Market Size by Country
10.3.1 South America Calcium Antagonists Sales in Volume by Country (2016-2026)
10.3.2 South America Calcium Antagonists Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Calcium Antagonists Sales by Type (2016-2026)
11.2 Middle East & Africa Calcium Antagonists Sales by Application (2016-2026)
11.3 Middle East & Africa Calcium Antagonists Market Size by Country
11.3.1 Middle East & Africa Calcium Antagonists Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Calcium Antagonists Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Calcium Antagonists Typical Distributors
12.3 Calcium Antagonists Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Calcium Antagonists Revenue by Type, (USD Million), 2021-2026
Table 2. Global Calcium Antagonists Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Calcium Antagonists Product and Services
Table 6. Pfizer Calcium Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Aventis Basic Information, Manufacturing Base and Competitors
Table 8. Aventis Major Business
Table 9. Aventis Calcium Antagonists Product and Services
Table 10. Aventis Calcium Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Searle Basic Information, Manufacturing Base and Competitors
Table 12. Searle Major Business
Table 13. Searle Calcium Antagonists Product and Services
Table 14. Searle Calcium Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Bayer Basic Information, Manufacturing Base and Competitors
Table 16. Bayer Major Business
Table 17. Bayer Calcium Antagonists Product and Services
Table 18. Bayer Calcium Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Major Business
Table 21. AstraZeneca Calcium Antagonists Product and Services
Table 22. AstraZeneca Calcium Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Knoll Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Knoll Pharmaceuticals Major Business
Table 25. Knoll Pharmaceuticals Calcium Antagonists Product and Services
Table 26. Knoll Pharmaceuticals Calcium Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Wyeth-Ayerst Basic Information, Manufacturing Base and Competitors
Table 28. Wyeth-Ayerst Major Business
Table 29. Wyeth-Ayerst Calcium Antagonists Product and Services
Table 30. Wyeth-Ayerst Calcium Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Major Business
Table 33. Novartis Calcium Antagonists Product and Services
Table 34. Novartis Calcium Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sanofi Basic Information, Manufacturing Base and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Calcium Antagonists Product and Services
Table 38. Sanofi Calcium Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Baiyunshan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Baiyunshan Pharmaceutical Major Business
Table 41. Baiyunshan Pharmaceutical Calcium Antagonists Product and Services
Table 42. Baiyunshan Pharmaceutical Calcium Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. South China Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 44. South China Pharmaceutical Group Major Business
Table 45. South China Pharmaceutical Group Calcium Antagonists Product and Services
Table 46. South China Pharmaceutical Group Calcium Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Tianjin Tanabe Seiyaku Basic Information, Manufacturing Base and Competitors
Table 48. Tianjin Tanabe Seiyaku Major Business
Table 49. Tianjin Tanabe Seiyaku Calcium Antagonists Product and Services
Table 50. Tianjin Tanabe Seiyaku Calcium Antagonists Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Calcium Antagonists Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global Calcium Antagonists Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Calcium Antagonists, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Calcium Antagonists Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and Calcium Antagonists Production Site of Key Manufacturer
Table 56. Global Calcium Antagonists Sales by Region (2016-2021e) & (K Units)
Table 57. Global Calcium Antagonists Sales by Region (2021-2026) & (K Units)
Table 58. Global Calcium Antagonists Revenue by Region (2016-2021e) & (USD Million)
Table 59. Global Calcium Antagonists Revenue by Region (2021-2026) & (USD Million)
Table 60. Global Calcium Antagonists Sales by Type (2016-2021e) & (K Units)
Table 61. Global Calcium Antagonists Sales by Type (2021-2026) & (K Units)
Table 62. Global Calcium Antagonists Revenue by Type (2016-2021e) & (USD Million)
Table 63. Global Calcium Antagonists Revenue by Type (2021-2026) & (USD Million)
Table 64. Global Calcium Antagonists Price by Type (2016-2021e) & (USD/Unit)
Table 65. Global Calcium Antagonists Price by Type (2021-2026) & (USD/Unit)
Table 66. Global Calcium Antagonists Sales by Application (2016-2021e) & (K Units)
Table 67. Global Calcium Antagonists Sales by Application (2021-2026) & (K Units)
Table 68. Global Calcium Antagonists Revenue by Application (2016-2021e) & (USD Million)
Table 69. Global Calcium Antagonists Revenue by Application (2021-2026) & (USD Million)
Table 70. Global Calcium Antagonists Price by Application (2016-2021e) & (USD/Unit)
Table 71. Global Calcium Antagonists Price by Application (2021-2026) & (USD/Unit)
Table 72. North America Calcium Antagonists Sales by Country (2016-2021e) & (K Units)
Table 73. North America Calcium Antagonists Sales by Country (2021-2026) & (K Units)
Table 74. North America Calcium Antagonists Revenue by Country (2016-2021e) & (USD Million)
Table 75. North America Calcium Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 76. North America Calcium Antagonists Sales by Type (2016-2021e) & (K Units)
Table 77. North America Calcium Antagonists Sales by Type (2021-2026) & (K Units)
Table 78. North America Calcium Antagonists Sales by Application (2016-2021e) & (K Units)
Table 79. North America Calcium Antagonists Sales by Application (2021-2026) & (K Units)
Table 80. Europe Calcium Antagonists Sales by Country (2016-2021e) & (K Units)
Table 81. Europe Calcium Antagonists Sales by Country (2021-2026) & (K Units)
Table 82. Europe Calcium Antagonists Revenue by Country (2016-2021e) & (USD Million)
Table 83. Europe Calcium Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 84. Europe Calcium Antagonists Sales by Type (2016-2021e) & (K Units)
Table 85. Europe Calcium Antagonists Sales by Type (2021-2026) & (K Units)
Table 86. Europe Calcium Antagonists Sales by Application (2016-2021e) & (K Units)
Table 87. Europe Calcium Antagonists Sales by Application (2021-2026) & (K Units)
Table 88. Asia-Pacific Calcium Antagonists Sales by Region (2016-2021e) & (K Units)
Table 89. Asia-Pacific Calcium Antagonists Sales by Region (2021-2026) & (K Units)
Table 90. Asia-Pacific Calcium Antagonists Revenue by Region (2016-2021e) & (USD Million)
Table 91. Asia-Pacific Calcium Antagonists Revenue by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific Calcium Antagonists Sales by Type (2016-2021e) & (K Units)
Table 93. Asia-Pacific Calcium Antagonists Sales by Type (2021-2026) & (K Units)
Table 94. Asia-Pacific Calcium Antagonists Sales by Application (2016-2021e) & (K Units)
Table 95. Asia-Pacific Calcium Antagonists Sales by Application (2021-2026) & (K Units)
Table 96. South America Calcium Antagonists Sales by Country (2016-2021e) & (K Units)
Table 97. South America Calcium Antagonists Sales by Country (2021-2026) & (K Units)
Table 98. South America Calcium Antagonists Revenue by Country (2016-2021e) & (USD Million)
Table 99. South America Calcium Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 100. South America Calcium Antagonists Sales by Type (2016-2021e) & (K Units)
Table 101. South America Calcium Antagonists Sales by Type (2021-2026) & (K Units)
Table 102. South America Calcium Antagonists Sales by Application (2016-2021e) & (K Units)
Table 103. South America Calcium Antagonists Sales by Application (2021-2026) & (K Units)
Table 104. Middle East & Africa Calcium Antagonists Sales by Country (2016-2021e) & (K Units)
Table 105. Middle East & Africa Calcium Antagonists Sales by Country (2021-2026) & (K Units)
Table 106. Middle East & Africa Calcium Antagonists Revenue by Country (2016-2021e) & (USD Million)
Table 107. Middle East & Africa Calcium Antagonists Revenue by Country (2021-2026) & (USD Million)
Table 108. Middle East & Africa Calcium Antagonists Sales by Type (2016-2021e) & (K Units)
Table 109. Middle East & Africa Calcium Antagonists Sales by Type (2021-2026) & (K Units)
Table 110. Middle East & Africa Calcium Antagonists Sales by Application (2016-2021e) & (K Units)
Table 111. Middle East & Africa Calcium Antagonists Sales by Application (2021-2026) & (K Units)
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Calcium Antagonists Typical Distributors
Table 115. Calcium Antagonists Typical Customers
List of Figures
Figure 1. Calcium Antagonists Picture
Figure 2. Global Calcium Antagonists Sales Market Share by Type in 2020
Figure 3. Dihydropyridine
Figure 4. Diltiazem
Figure 5. Verapamil
Figure 6. Others
Figure 7. Global Calcium Antagonists Sales Market Share by Application in 2020
Figure 8. Hypertension
Figure 9. Coronary Artery Disease
Figure 10. Arrhythmia
Figure 11. Ohers
Figure 12. Global Calcium Antagonists Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global Calcium Antagonists Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. United States Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Canada Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Mexico Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Germany Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. France Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. United Kingdom Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Russia Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Italy Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. China Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Japan Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Korea Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. India Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Southeast Asia Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Australia Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Brazil Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Egypt Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Saudi Arabia Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. South Africa Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Turkey Calcium Antagonists Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Global Calcium Antagonists Sales (2016-2026) & (K Units)
Figure 34. Global Calcium Antagonists Production Capacity (2016-2026) & (K Units)
Figure 35. Global Calcium Antagonists Production Capacity by Geographic Region: 2020 VS 2021
Figure 36. Calcium Antagonists Market Drivers
Figure 37. Calcium Antagonists Market Restraints
Figure 38. Calcium Antagonists Market Trends
Figure 39. Global Calcium Antagonists Sales Market Share by Manufacturer in 2020
Figure 40. Global Calcium Antagonists Revenue Market Share by Manufacturer in 2020
Figure 41. Calcium Antagonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 42. Top 3 Calcium Antagonists Manufacturer (Revenue) Market Share in 2020
Figure 43. Top 6 Calcium Antagonists Manufacturer (Revenue) Market Share in 2020
Figure 44. Global Calcium Antagonists Sales Market Share by Region (2016-2026)
Figure 45. Global Calcium Antagonists Revenue Market Share by Region (2016-2026)
Figure 46. North America Calcium Antagonists Revenue (2016-2026) & (USD Million)
Figure 47. Europe Calcium Antagonists Revenue (2016-2026) & (USD Million)
Figure 48. Asia-Pacific Calcium Antagonists Revenue (2016-2026) & (USD Million)
Figure 49. South America Calcium Antagonists Revenue (2016-2026) & (USD Million)
Figure 50. Middle East & Africa Calcium Antagonists Revenue (2016-2026) & (USD Million)
Figure 51. Global Calcium Antagonists Sales Market Share by Type (2016-2026)
Figure 52. Global Calcium Antagonists Revenue Market Share by Type (2016-2026)
Figure 53. Global Calcium Antagonists Price by Type (2016-2026) & (USD/Unit)
Figure 54. Global Calcium Antagonists Sales Market Share by Application (2016-2026)
Figure 55. Global Calcium Antagonists Revenue Market Share by Application (2016-2026)
Figure 56. Global Calcium Antagonists Price by Application (2016-2026) & (USD/Unit)
Figure 57. North America Calcium Antagonists Sales Market Share by Country (2016-2026)
Figure 58. North America Calcium Antagonists Revenue Market Share by Country (2016-2026)
Figure 59. North America Calcium Antagonists Sales Market Share by Type (2016-2026)
Figure 60. North America Calcium Antagonists Sales Market Share by Application (2016-2026)
Figure 61. Europe Calcium Antagonists Sales Market Share by Country (2016-2026)
Figure 62. Europe Calcium Antagonists Revenue Market Share by Country (2016-2026)
Figure 63. Europe Calcium Antagonists Sales Market Share by Type (2016-2026)
Figure 64. Europe Calcium Antagonists Sales Market Share by Application (2016-2026)
Figure 65. Asia-Pacific Calcium Antagonists Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Calcium Antagonists Revenue Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Calcium Antagonists Sales Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Calcium Antagonists Sales Market Share by Application (2016-2026)
Figure 69. South America Calcium Antagonists Sales Market Share by Country (2016-2026)
Figure 70. South America Calcium Antagonists Revenue Market Share by Country (2016-2026)
Figure 71. South America Calcium Antagonists Sales Market Share by Type (2016-2026)
Figure 72. South America Calcium Antagonists Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Calcium Antagonists Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Calcium Antagonists Revenue Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Calcium Antagonists Sales Market Share by Type (2016-2026)
Figure 76. Middle East & Africa Calcium Antagonists Sales Market Share by Application (2016-2026)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source
α-アドレナリン受容体拮抗薬の世界市場2018-2025 α-adrenoreceptor antagonists are a class of pharmacological agents that act as antagonists on α-adrenergic receptors (α-adrenoceptors).In 2018, the global α-adrenoreceptor Antagonists market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this…- AT1受容体拮抗薬の世界市場2018-2025 AT1 receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors…
- アンジオテンシン受容体拮抗薬の世界市場2018-2025 Angiotensin II receptor antagonists are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of A…
- ビタミンK拮抗薬（VKA）の世界市場2018-2025 Vitamin K is a kind of substance with biological activity of leaf green quinone.Rising demand from Asia-Pacific region a major driver for the growth of the market. In 2018, the global Vitamin K Antagonists (VKA) market size was xx million US$ and is forecast to xx million US in 2025, growing at a CA…
- 世界のケイ化カルシウム市場 2021：企業別、地域別、種類・用途別 The Calcium Silicide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…